| Literature DB >> 35251820 |
Muhammad Amin Chinoy1, Kazim Hussain1, Salman Javed1.
Abstract
Objective To compare the frequency of serum vitamin D levels in patients with and without distal radius fracture. Introduction Hypovitaminosis D is a common problem worldwide. Deficiency of vitamin D is not only associated with musculoskeletal problems, but also with chronic diseases like diabetes mellitus, cardiovascular disease and cancer. Vitamin D deficiency results in bone pain, aggravating osteoporosis and fragility fractures. Distal radius fractures are common upper limb fractures, mostly in the elderly population. Low serum levels of vitamin D have been reported to result in increased risk of distal radius fracture. Methodology This study was conducted at The Indus Hospital Karachi, from 1st March 2020 to 31st August 2020. Consecutive non-probability sampling was done. Patients aged between 20 to 80 years with and without distal radius fractures were enrolled and serum vitamin D levels were compared. Results A total of 130 patients were enrolled in this study, out of which 70 (53.8%) were males. The median (IQR) vitamin D, calcium, alkaline phosphate level, and albumin was 14.8 (9.5-23) ng/ml, 9.2 (8.9-9.5) ng/ml, 91 (77.3-111) U/L, and 4.2 (4-4.5) g/dl, respectively. No significant association between distal radius fracture and vitamin D levels was found in males, whereas a significantly higher proportion of females with no fracture had a mild-moderate deficiency in comparison to females with fracture. Conclusion No significant association was noted between patients with and without distal radius fracture and vitamin D levels, however, we recommend more studies on this topic so that more comprehensive results can be obtained.Entities:
Keywords: alkaline phosphate; calcium; distal radius; fractures; vitamin d
Year: 2022 PMID: 35251820 PMCID: PMC8890607 DOI: 10.7759/cureus.21749
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Demographic characteristics of participants (n=130)
| Age (Years) | |
| Min-Max | 20-79 |
| Median (IQR) | 41 (30.8-51) |
| Weight (kg) | |
| Min-Max | 44-120 |
| Median (IQR) | 75 (67-80) |
| Height (cm) | |
| Min-Max | 117-183.5 |
| Median (IQR) | 170 (161.8-175) |
| BMI (kg/m2) | |
| Min-Max | 16.1-46.6 |
| Median (IQR) | 25.5 (23.7-28) |
| Duration of sun exposure (hours) | |
| Min-Max | 0.1-9 |
| Median (IQR) | 1 (0.5-2) |
| Gender; n (%) | |
| Male | 70 (53.8) |
| Female | 60 (46.2) |
| Total | 130 (100) |
| Menopause (for females); n (%) | |
| No | 44 (33.8) |
| Yes | 16 (12.3) |
| Missing | 70 (53.8) |
| Total | 130 (100) |
| Addiction; n (%) | |
| Smoker | 16 (12.3) |
| Occasional Smoker | 12 (9.2) |
| Non-Smoker | 102 (75.5) |
| Total | 130 (100) |
| Comorbidity; n (%) | |
| No | 81 (62.3) |
| Yes | 49 (37.7) |
| -Diabetes | 14 (10.4) |
| -Hypertension | 23 (17) |
| -Other | 17 (12.6) |
| Distal Radius Fracture; n (%) | |
| Extra-articular | 31 (23.8) |
| Intra-articular | 34 (26.2) |
| No distal radius fracture | 65 (50) |
| Total | 130 (100) |
| Occupation; n (%) | |
| Employed | 51 (41.1) |
| Unemployed | 12 (9.7) |
| Housewife | 49 (39.5) |
| Students | 12 (9.7) |
Laboratory findings of the participants
| Vitamin D level (ng/ml) | |
| Min-Max | 3.8-154.2 |
| Median (IQR) | 14.8 (9.5-23) |
| Calcium level (mg/dl) | |
| Min-Max | 3.7-10.2 |
| Median (IQR) | 9.2 (8.9-9.5) |
| Alkaline Phosphatase level (U/L) | |
| Min-Max | 42-470 |
| Median (IQR) | 91 (77.3-111) |
| Albumin level (g/dl) | |
| Min-Max | 2.3-9.8 |
| Median (IQR) | 4.2 (4-4.5) |
| Vitamin D level | n% |
| Severe deficiency | 33 (25.4) |
| Normal | 72 (55.4) |
| Mild to moderate deficiency | 22 (16.9) |
| Toxicity | 3 (2.3) |
| Total | 130 (100) |
Association of vitamin D levels with distal radius fracture post-stratification of various participants’ characteristics
| Participants' characteristics | Vit D levels | Distal Radius Fracture | Total | p-value | |
| Yes | No | ||||
| n (%) | n (%) | ||||
| Gender | |||||
| Male | Severe deficiency | 6(16.7) | 5(14.7) | 11(15.7) | 0.116ꬸ |
| Normal | 27(75) | 19(55.9) | 46(65.7) | ||
| Mild to moderate deficiency | 3(8.3) | 9(26.5) | 12(17.1) | ||
| Toxicity | 0(0) | 1(2.9) | 1(1.4) | ||
| Total | 36(100) | 34(100) | 70(100) | ||
| Female | Severe deficiency | 11(37.9) | 11(35.5) | 22(36.7) | 0.032*ꬸ |
| Normal | 16(55.2) | 10(32.3) | 26(43.3) | ||
| Mild to moderate deficiency | 1(3.4) | 9(29)b | 10(16.7) | ||
| Toxicity | 1(3.4) | 1(3.2) | 2(3.3) | ||
| Total | 29(100) | 31(100) | 60(100) | ||
| Age in years | |||||
| ≤41 | Severe deficiency | 9(30) | 9(24.3) | 18(26.9) | 0.012*ꬸ |
| Normal | 21(70) | 18(48.6) | 39(58.2) | ||
| Mild to moderate deficiency | 0(0) | 8(21.6)b | 8(11.9) | ||
| Toxicity | 0(0) | 2(5.4) | 2(3) | ||
| Total | 30(100) | 37(100) | 67(100) | ||
| >41 | Severe deficiency | 8(22.9) | 7(25) | 15(23.8) | 0.067ꬸ |
| Normal | 22(62.9) | 11(39.3) | 33(52.4) | ||
| Mild to moderate deficiency | 4(11.4) | 10(35.7) | 14(22.2) | ||
| Toxicity | 1(2.9) | 0(0) | 1(1.6) | ||
| Total | 35(100) | 28(100) | 63(100) | ||
| BMI category | |||||
| ≤25 | Severe deficiency | 9(29) | 4(13.8) | 13(21.7) | 0.003*ꬸ |
| Normal | 21(67.7) | 15(51.7) | 36(60) | ||
| Mild to moderate deficiency | 0(0) | 9(31)b | 9(15) | ||
| Toxicity | 1(3.2) | 1(3.4) | 2(3.3) | ||
| Total | 31(100) | 29(100) | 60(100) | ||
| >25 | Severe deficiency | 8(23.5) | 12(33.3) | 20(28.6) | 0.112ꬸ |
| Normal | 22(64.7) | 14(38.9) | 36(51.4) | ||
| Mild to moderate deficiency | 4(11.8) | 9(25) | 13(18.6) | ||
| Toxicity | 0(0) | 1(2.8) | 1(1.4) | ||
| Total | 34(100) | 36(100) | 70(100) | ||
| Menopause (for females) | |||||
| No | Severe deficiency | 9(42.9) | 8(34.8) | 17(38.6) | 0.014*ꬸ |
| Normal | 12(57.1) | 7(30.4) | 19(43.2) | ||
| Mild to moderate deficiency | 0(0) | 7(30.4)B | 7(15.9) | ||
| Toxicity | 0(0) | 1(4.3) | 1(2.3) | ||
| Total | 21(100) | 23(100) | 44(100) | ||
| Yes | Severe deficiency | 2(25) | 3(37.5) | 5(31.3) | 1.000ꬸ |
| Normal | 4(50) | 3(37.5) | 7(43.8) | ||
| Mild to moderate deficiency | 1(12.5) | 2(25) | 3(18.8) | ||
| Toxicity | 1(12.5) | 0(0) | 1(6.3) | ||
| Total | 8(100) | 8(100) | 16(100) | ||
| Sun exposure in hours | |||||
| ≤1 hour | Severe deficiency | 10(26.3) | 12(29.3) | 22(27.8) | 0.316ꬸ |
| Normal | 23(60.5) | 18(43.9) | 41(51.9) | ||
| Mild to moderate deficiency | 4(10.5) | 10(24.4) | 14(17.7) | ||
| Toxicity | 1(2.6) | 1(2.4) | 2(2.5) | ||
| Total | 38(100) | 41(100) | 79(100) | ||
| > 1 hour | Severe deficiency | 7(25.9) | 4(16.7) | 11(21.6) | 0.003*ꬸ |
| Normal | 20(74.1) | 11(45.8)b | 31(60.8) | ||
| Mild to moderate deficiency | 0(0) | 8(33.3)b | 8(15.7) | ||
| Toxicity | 0(0) | 1(4.2) | 1(2) | ||
| Total | 27(100) | 24(100) | 51(100) | ||
| Albumin | |||||
| ≤4.2 | Severe deficiency | 9(28.1) | 12(30.8) | 21(29.6) | 0.253ꬸ |
| Normal | 19(59.4) | 16(41) | 35(49.3) | ||
| Mild to moderate deficiency | 3(9.4) | 10(25.6) | 13(18.3) | ||
| Toxicity | 1(3.1) | 1(2.6) | 2(2.8) | ||
| Total | 32(100) | 39(100) | 71(100) | ||
| >4.2 | Severe deficiency | 8(24.2) | 4(15.4) | 12(20.3) | 0.010*ꬸ |
| Normal | 24(72.7) | 13(50) | 37(62.7) | ||
| Mild to moderate deficiency | 1(3) | 8(30.8)b | 9(15.3) | ||
| Toxicity | 0(0) | 1(3.8) | 1(1.7) | ||
| Total | 33(100) | 26(100) | 59(100) | ||
| Calcium level | |||||
| ≤9.2 | Severe deficiency | 10(32.3) | 11(28.9) | 21(30.4) | 0.106ꬸ |
| Normal | 18(58.1) | 17(44.7) | 35(50.7) | ||
| Mild to moderate deficiency | 2(6.5) | 10(26.3) | 12(17.4) | ||
| Toxicity | 1(3.2) | 0(0) | 1(1.4) | ||
| Total | 31(100) | 38(100) | 69(100) | ||
| >9.2 | Severe deficiency | 7(20.6) | 5(18.5) | 12(19.7) | 0.016*ꬸ |
| Normal | 25(73.5) | 12(44.4)b | 37(60.7) | ||
| Mild to moderate deficiency | 2(5.9) | 8(29.6)b | 10(16.4) | ||
| Toxicity | 0(0) | 2(7.4) | 2(3.3) | ||
| Total | 34(100) | 27(100) | 61(100) | ||
| Alkaline phosphate level | |||||
| ≤9.1 | Severe deficiency | 7(21.2) | 8(24.2) | 15(22.7) | 0.172ꬸ |
| Normal | 24(72.7) | 18(54.5) | 42(63.6) | ||
| Mild to moderate deficiency | 1(3) | 6(18.2) | 7(10.6) | ||
| Toxicity | 1(3) | 1(3) | 2(3) | ||
| Total | 33(100) | 33(100) | 66(100) | ||
| >9.1 | Severe deficiency | 10(31.3) | 8(25) | 18(28.1) | 0.020*ꬸ |
| Normal | 19(59.4) | 11(34.4)b | 30(46.9) | ||
| Mild to moderate deficiency | 3(9.4) | 12(37.5)b | 15(23.4) | ||
| Toxicity | 0(0) | 1(3.1) | 1(1.6) | ||
| Total | 32(100) | 32(100) | 64(100) | ||
| Smoking Status | |||||
| Smoker | Normal | 7(77.8) | 4(57.1) | 11(68.8) | 0.758ꬸ |
| Mild to moderate deficiency | 2(22.2) | 2(28.6) | 4(25) | ||
| Toxicity | 0(0) | 1(14.3) | 1(6.3) | ||
| Total | 9(100) | 7(100) | 16(100) | ||
| Occasional Smoker | Severe deficiency | 2(25) | 1(25) | 3(25) | 1.000ꬸ |
| Normal | 6(75) | 3(75) | 9(75) | ||
| Total | 8(100) | 4(100) | 12(100) | ||
| No Smoker | Severe deficiency | 15(31.3) | 15(27.8) | 30(29.4) | 0.003*ꬸ |
| Normal | 30(62.5) | 22(40.7)b | 52(51) | ||
| Mild to moderate deficiency | 2(4.2) | 16(29.6)b | 18(17.6) | ||
| Toxicity | 1(2.1) | 1(1.9) | 2(2) | ||
| Total | 48(100) | 54(100) | 102(100) | ||
| Comorbidity | |||||
| No | Severe deficiency | 11(23.4) | 7(20.6) | 18(22.2) | 0.007*ꬸ |
| Normal | 35(74.5) | 18(52.9)b | 53(65.4) | ||
| Mild to moderate deficiency | 1(2.1) | 8(23.5)b | 9(11.1) | ||
| Toxicity | 0(0) | 1(2.9) | 1(1.2) | ||
| Total | 47(100) | 34(100) | 81(100) | ||
| Yes | Severe deficiency | 6(33.3) | 9(29) | 15(30.6) | 0.629ꬸ |
| Normal | 8(44.4) | 11(35.5) | 19(38.8) | ||
| Mild to moderate deficiency | 3(16.7) | 10(32.3) | 13(26.5) | ||
| Toxicity | 1(5.6) | 1(3.2) | 2(4.1) | ||
| Total | 18(100) | 31(100) | 49(100) | ||
| P<0.05, ꬸ Fisher's exact | |||||